Brenntag SE Faces Fresh Downgrade Amid Weak Demand and Rising Costs
Brenntag SE is facing renewed pressure after an unnamed analyst downgraded the stock to 'Hold' with a €53 price target. The chemical distributor's shares closed at €49.20 on 12 March 2026, showing only a slight gain of 0.24% on Xetra. Meanwhile, Goldman Sachs maintained a more optimistic 'Buy' rating with a €64 target, highlighting mixed views on the company's outlook.
The downgrade comes as Brenntag SE struggles with weak demand and rising input costs. Its latest quarterly results revealed ongoing margin weakness, reflecting sluggish activity in key sectors like automotive and construction. While the company has grown its market share through acquisitions, organic growth remains difficult to achieve.
Analysts expect modest volume growth in 2026, driven mainly by specialty chemicals. However, the broader chemical distribution sector continues to face challenges from low global demand. Brenntag's business model, which relies on price fluctuations in chemicals and ingredients, has not been enough to offset these pressures. Other financial institutions have also adjusted their stance. Both Deutsche Bank and Warburg Research recently lowered their ratings to 'Hold'. Earlier, Jefferies had set a €42 price target, suggesting a potential 15% downside, though this was not linked to the latest downgrade.
Brenntag SE's stock now trades near €49.20, with conflicting analyst views shaping its near-term prospects. The company's ability to navigate weak demand and cost pressures will determine whether it can stabilise margins and deliver growth. For now, the market remains cautious amid broader sector challenges.
